| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
2e-08 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-08 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-07 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-07 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-07 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
3e-07 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-06 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-06 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |